idarubicin has been researched along with Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, CA; Krailo, MD; Liu-Mares, W; Reaman, GH; Scheithauer, B; Steinherz, L | 1 |
| Beijnen, JH; Boogerd, W; Tjahja, IS; van de Sandt, MM | 1 |
2 trial(s) available for idarubicin and Astrocytoma
| Article | Year |
|---|---|
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.
Topics: Adolescent; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Infusions, Intravenous; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive, Peripheral | 1998 |
Penetration of idarubicin into malignant brain tumor tissue.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Breast Neoplasms; Drug Administration Schedule; Glioblastoma; Humans; Idarubicin | 1999 |